Track the CARLSMED, INC. share price and the full directors' dealings record of the company, a listed equity based in United States. Shares trade on the US market, under the authority of SEC (Form 4). Market capitalisation: €2.5bn. The latest transaction was disclosed on 22 June 2026 (Attribution). Among the most active insiders: Cordonnier Michael. The full history is openly available.
18
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate CARLSMED, INC. Strong Buy (bullish), based on 12 analysts. Average price target: US$62.05.
30Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.